This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.
Epstein-Barr virus, human cytomegalovirus, (and) herpes simplex virus have been implicated in the pathogenesis of a subset of breast cancers, according to a study published online in advance of September 2014 in the journal Advances in Anatomic Pathology. (1) The CBCD reviews the study and recommends two natural herpes remedies.
Rochester, NY (PRWEB) August 14, 2014
Many studies found a link between herpes viruses and breast cancer. As Dr. Akhter and colleagues wrote, In several published studies, viruses such as human mammary tumor virus, human papillomaviruses, Epstein-Barr virus, human cytomegalovirus, herpes simplex virus, and measles virus have been implicated in the pathogenesis of a subset of breast cancers (BC). (1) Dr. Akhter and colleagues are from the King Faisal Specialist Hospital and Research Center in Saudi Arabia. These are important findings since Dr. Kakpenova wrote in another study that the most frequent cancer among women is breast cancer (and) we evaluated to what extent infection is significant, and concluded that members of the herpesvirus (family) definitely associate with breast cancer. (See Infectious Agents and Cancer, from September 2, 2013) (2) Interestingly, Dr. Kakpenova wrote in the same study that we propose that preventing and treating infections may possibly stop or even eliminate certain types of cancers. (2) Dr. Kakpenova is from the Nazarbayev University in Kazakhstan.
Click to learn more about herpes viruses and herpes symptoms.
The Center for the Biology of Chronic Disease (CBCD) recommends that people who suspect an infection with the herpes virus (HSV-2 or HSV-1) take Novirin or Gene-Eden-VIR. The formula of these natural antiviral products was tested by Hanan Polansky and Edan Itzkovitz from the CBCD in two clinical studies that followed FDA guidelines. The studies showed that the Gene-Eden-VIR and Novirin formula is effective against the herpes simplex virus, and other viruses. The clinical studies were published in the peer reviewed, medical journal Pharmacology & Pharmacy, the first, in a special edition on Advances in Antiviral Drugs. Study authors wrote that, individuals infected with the HSV reported a safe decrease in their symptoms following treatment with Gene-Eden-VIR. (3) The study authors also wrote that, we observed a statistically significant decrease in the severity, duration, and frequency of symptoms. (3)
Novirin and Gene-Eden-VIR are natural antiviral dietary supplements. Their formula contains five natural ingredients: Selenium, Camellia Sinesis Extract, Quercetin, Cinnamomum Extract, and Licorice Extract. The first ingredient is a trace element, and the other four are plant extracts. Each ingredient and its dose was chosen through a scientific approach. Scientists at polyDNA, the company that invented and patented the formula, scanned thousands of scientific and medical papers published in various medical and scientific journals, and identified the safest and most effective natural ingredients against latent viruses. To date, Novirin and Gene-Eden-VIR are the only natural antiviral products on the market with published clinical studies that support their claims.
Recently, Mexican researchers confirmed that HCMV DNA (DNA from the cytomegalovirus, which is a member of the herpes virus family) was found in breast cancer tumors. (See Infectious Agents and Cancer, from April 4, 2013) (4) Another study published in PLoS One on February 22, 2013 showed the presence of HCMV proteins in breast cancer tumors. (5)
Greg Bennett from the CBCD said, We are not surprised by these findings. In fact, these results provide further evidence consistent with the Theory of Microcompetition proposed by Dr. Hanan Polansky and discussed in his ground breaking book, Microcompetition with Foreign DNA and the Origin of Chronic Disease. Weve long believed that latent viruses from the herpes virus family of viruses (like CMV) are the underlying cause of many major diseases.
Greg Bennett further noted, In the nucleus, Microcompetition between the foreign N-boxes and the human N-boxes in the human genes can lead to a major disease. When the foreign N-boxes belong to a virus, microcompetition between the viral DNA and the human DNA can lead to disease even when the virus is latent (dormant) or the viral DNA is broken into pieces and cannot express proteins. As predicted by Dr. Hanan Polansky, many studies found fragments of DNA that belong to these viruses in tumors, clogged arteries (arterial plaque), arthritic joints, and other diseased tissues.
Click to learn more about Microcompetition with Foreign DNA.
The CBCD points out that while there are antiviral drugs designed to target active herpes viruses, most oral antiviral therapy decreases the duration and the associated pain of an outbreak by merely one day. (3) To target latent herpes viruses, the CBCD recommends Novirin or Gene-Eden-VIR.
(1) Akhter J1, Ali Aziz MA, Al Ajlan A, Tulbah A, Akhtar M. Breast Cancer: Is There a Viral Connection? Adv Anat Pathol. 2014 Sep;21(5):373-381.
(2) Kenneth Alibek12, Ainur Kakpenova1*, Assel Mussabekova1, Marzhan Sypabekova1 and Nargis Karatayeva1 Role of viruses in the development of breast cancer. Published 2 September 2013
(3) Polansky H, Itzkovitz E. Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Pharmacology & Pharmacy, 2013, 4, 1-8
(4) Dolores Utrera-Barillas1, Hilda-Alicia Valdez-Salazar2, David Gómez-Rangel3, Isabel Alvarado-Cabrero4, Penélope Aguilera5, Alejandro Gómez-Delgado2 and Martha-Eugenia Ruiz-Tachiquin6* Is human cytomegalovirus associated with breast cancer progression? Published 4 April 2013.
(5) Chato Taher, Jana de Boniface, Abdul-Aleem Mohammad, Piotr Religa, Johan Hartman, Koon-Chu Yaiw, Jan Frisell, Afsar Rahbar equal contributor, Cecilia Söderberg-Naucler High Prevalence of Human Cytomegalovirus Proteins and Nucleic Acids in Primary Breast Cancer and Metastatic Sentinel Lymph Nodes. Published February 22, 2013.
For the original version on PRWeb visit: http://www.prweb.com/releases/2014/08/prweb12091934.htm
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact firstname.lastname@example.org.